Abstract:Mesenchymal stem cells (MSCs) have both multi-lineage differentiation potential and immunosuppressive properties, making them ideal candidates for regenerative medicine. However, their immunosuppressive properties potentially increase the risk of cancer progression and opportunistic infections. In this study, MSCs isolated from human umbilical cord blood (UCMSCs) and adult bone marrow (BMMSCs) were infected with human cytomegalovirus (HCMV). Cytopathic changes were observed 10 days post infection. PCR products amplified from genomic DNA and cDNA were used to confirm the HCMV infection of the UCMSCs and BMMSCs. Real-time PCR was conducted to quantify the expression of immunomodulatory molecules, including cytokines, chemokines, growth factors, adhesion molecules and cancer-related genes. Our results indicate high upregulation of the majority of these molecules, including many growth factors, tumor necrosis factor alpha, interleukin-8, interleukin-6 and interferon gamma. Adhesion molecules (VCAM-1, TCAM-1 and selectin-E) were downregulated in the infected UCMSCs and BMMSCs. Antibody chip array evaluation of cell culture media indicated that the growth factor secretion by UCMSCs and BMMSCs was greatly influenced (p < 0.001) by HCMV. The stimulation of MSCs with HCMV led to the activation of downstream signaling pathways, including pSTAT3 and Wnt2. Our results show that HCMV can significantly alter the functions of both UCMSCs and BMMSCs, although not in the same way or to the same extent. In both cases, there was an increase in the expression of proangiogenic factors in the microenvironment following HMCV infection. The discrepancy between the two cell types may be explained by their different developmental origin, although further analysis is necessary. Future studies should decipher the underlying mechanism by which HCMV controls MSCs, which may lead to the development of new therapeutic treatments.

Mesenchymal stem cells detect and defend against gammaherpesvirus infection via the cGAS-STING pathway

CXCR4-transduced Mesenchymal Stem Cells Protect Mice Against Graft-Versus-host Disease.

The battle between the innate immune cGAS-STING signaling pathway and human herpesvirus infection

Insights on the Cgas-Sting Signaling Pathway During Herpesvirus Infections

Pivotal Roles of Cgas-Cgamp Signaling in Antiviral Defense and Immune Adjuvant Effects

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

hMSCs treatment attenuates murine herpesvirus-68 (MHV-68) pneumonia through altering innate immune response via ROS/NLRP3 signaling pathway

Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-Versus-Host Disease Via Cd39-Cd73-Adenosine and Ido Signals

Human Gingiva-Derived Mesenchymal Stromal Cells Inhibit Graft-Versus-Host Disease Through CD39 and IDO.

Mesenchymal Stem Cells Prevent Overwhelming Inflammation and Reduce Infection Severity Via Recruiting CXCR3+ Regulatory T Cells

Transfer of Cgamp into Bystander Cells Via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.

Gene Expression Profiles of Various Cytokines in Mesenchymal Stem Cells Derived from Umbilical Cord Tissue and Bone Marrow Following Infection with Human Cytomegalovirus.

Mir-23A/b Suppress Cgas-Mediated Innate and Autoimmunity

Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates Cgas/sting-Mediated Antiviral Innate Immunity

Human gingiva-derived mesenchymal stromal cells inhibit graft-versus-host disease through CD39 and IDO (THER5P.844)

Reduction in Murine Acute GVHD Severity by Human Gingival Tissue-Derived Mesenchymal Stem Cells Via the CD39 Pathways

Advances in cGAS-STING Signaling Pathway and Diseases

Immunomodulatory Effects of Mesenchymal Stem Cells Involved in Favoring Type 2 T Cell Subsets

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein

Import of extracellular 2'-3'cGAMP by the folate transporter, SLC19A1, establishes an antiviral response that limits herpes simplex virus-1

Herpes Simplex Virus-1 targets the 2’-3’cGAMP importer SLC19A1 as an antiviral countermeasure